Daclizumab: outcome of phase III trials and mechanism of action

Author: Vincenti F.   Nashan B.   Light S.  

Publisher: Elsevier

ISSN: 0041-1345

Source: Transplantation Proceedings, Vol.30, Iss.5, 1998-08, pp. : 2155-2158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content